| our findings indicate that LADCs with ALK, RET, and ROS1 fusions develop exclusively via their dependence on these oncogene fusions. | None |
| This study demonstrated that the RET-G691S non-synonymous polymorphism enhances in vitro the oncogenic activity of RET-S891A, and that the phenotype was observed in the RET-G691S/S891A patients. | None |
| Identification of Novel Small Molecule Inhibitors of Oncogenic RET Kinase. | None |
| A NOVEL DOUBLE MUTATION VAL648ILE AND VAL804LEU OF RET PROTO-ONCOGENE IN MULTIPLE ENDOCRINE NEOPLASIA TYPE 2. | None |
| Data show that heat shock protein 90 (HSP90) inhibitor 17-DMAG caused loss of ret proto-oncogene protein (RET) and proto-oncogene protein erbB-3 (ERBB3) phosphorylation and lead to rapid cell death. | None |
| Human ret proto-oncogene mapped to chromosome 10q11.2. | None |
| Activation of the ret-II oncogene without a sequence encoding a transmembrane domain and transforming activity of two ret-II oncogene products differing in carboxy-termini due to alternative splicing. | None |
| GFRA1 regulates AMPK-dependent autophagy by promoting SRC phosphorylation independent of proto-oncogene RET kinase | None |
| A p.C634W mutation in ret proto-oncogene protein (RET) has been detected in a family affected with multiple endocrine neoplasia type 2A (MEN2A), in which most carriers have developed clinical symptoms. | None |
| RET knockdown significantly decreased xenografts tumor growth in vivo, confirming the oncogenic impact of RET signaling in vivo. | None |
| An oncogenic role of non-mutated Ret in the mammary gland. | None |
| Data show that CCDC6-ret proto-oncogene (RET) was sufficient to confer resistance to EGFR tyrosine kinase inhibitors (TKI). | None |
| Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains. | None |
| Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating RET Alterations and Oncogenic Signaling Pathway Aberrations. | None |
| the rs2435357 and rs1800858 polymorphisms in the RET proto-oncogene might be associated with Hirschsprung disease risk (Meta-Analysis) | None |
| Molecular cloning and characterization of human ret-II oncogene. | None |
| Characterization of RET proto-oncogene 3 splicing variants and polyadenylation sites: a novel C-terminus for RET. | None |
| The physical map of the human RET proto-oncogene. | None |
| RET proto-oncogene mutations and rearrangements in endocrine diseases. | None |
| Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations. | None |